查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2049663

血液製品市場報告：按產品類型、抗血栓/抗凝血類型、應用和地區分類（2026-2034 年）

Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2025年全球血液製品市場規模達481億美元。展望未來，IMARC Group預測，2026年至2034年間，該市場將以3.82%的複合年成長率成長，到2034年達到681億美元。推動市場擴張的因素包括：慢性病盛行率上升、政府主導的改善醫療基礎設施的舉措、公眾意識的提高促使更多捐血、血液處理技術的快速發展以及個性化醫療的日益普及。

血液製品市場趨勢：

慢性病盛行率增加

心血管疾病、癌症和糖尿病等慢性疾病的日益流行是推動血液製品市場發展趨勢的主要積極因素。產業研究表明，美國約有1.29億人患有至少一種重大慢性疾病。這些疾病會導致貧血、凝血障礙和免疫系統缺陷等併發症，需要頻繁輸血、血小板替代療法和血漿療法。例如，根據美國國家血液採集和使用調查（NBCUS）報告，2021年美國共輸注了1076.4萬單位全血來源和透過血球分離術獲得的紅血球。此外，全球人口老化也在推動該行業的擴張，因為易患慢性疾病及其併發症的老年人數量不斷增加，從而提高了輸血需求。

政府措施的引入和醫療基礎設施的發展

政府為改善醫療基礎建設、確保血液供應穩定而採取的各項措施，正在擴大血液製品市場規模。政府日益重視鼓勵捐血、改善血庫設施，並加強投入以提高血液製品的整體安全性和可及性，這些措施都在推動市場成長。例如，印度政府透過輸血服務，為1131家公共和慈善血庫提供支持，支援領域包括人員配備、血袋和檢測套組採購、開展自願捐血活動以及資訊、教育和溝通（IEC）活動。此外，各國政府正在實施嚴格的措施，以確保血液製品的品質和安全，這有助於建立醫護人員和病患之間的信任。例如，印度政府推出的「e-RaktKosh」系統，是一個用於監控血庫的綜合性血庫管理資訊系統，將所有血庫連接到一個統一的網路中。

提高公眾意識，增加捐血

人們對捐血重要性的認知不斷提高，全球捐血人數持續成長，推動了血液製品市場佔有率的擴大。在美國，每年約有680萬人捐血，採集了1,360萬單位的全血和紅血球。此外，各國政府、非政府組織和醫療機構主導的公共衛生宣傳活動和計劃，提高了公眾對捐血救命重要性的認知，促進了市場成長。同時，已開發國家和開發中國家建立更系統化、更規範的捐血體系，確保血液供應的穩定可靠，也推動了市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球血液製品市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 全血
    • 主要部分
      • 紅血球
      • 粒細胞
      • 電漿
      • 血小板
  • 血液成分
    • 主要部分
      • 全血成分
      • 濃縮紅血球
      • 白血球耗竭的紅血球
      • 冷凍血漿
      • 血小板濃縮液
      • 冷凍機配方
  • 血液製品

第7章 市場區隔：依抗血栓及抗凝血藥物類型分類

  • 血小板凝集抑制劑
    • 主要部分
      • 糖蛋白抑制劑
      • COX抑制劑
      • ADP拮抗劑
      • 其他
  • 線性溶劑
    • 主要部分
      • 組織型胞漿素原原活化劑（TPA）
      • 鏈球菌激酶
      • 尿激酶
  • 抗凝血劑
    • 主要部分
      • 肝素
      • 維生素K拮抗劑
      • 直接凝血酶抑制劑
      • 直接作用於Xa因子的抑制劑

第8章 市場細分：按應用分類的抗血栓和抗凝血藥物

  • 血小板增多症
  • 肺動脈栓塞
  • 腎功能障礙
  • 心絞痛和血管併發症
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • GlaxoSmithKline PLC
    • Johnson & Johnson Services Inc.
    • LEO Pharma A/S
    • Pfizer Inc.
    • Portola Pharmaceuticals Inc.（Alexion Pharmaceuticals Inc.）
    • Sanofi SA
Product Code: SR112026A4552

The global blood preparation market size reached USD 48.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 68.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.82% during 2026-2034.The market is expanding due to the rising prevalence of chronic diseases, imposition of government initiatives that improve healthcare infrastructure, growing public awareness leading to increased blood donations, rapid advancements in blood processing technology, and the increasing adoption of personalized medicine.

Blood Preparation Market Trends:

Increasing Prevalence of Chronic Diseases

The rise in chronic diseases, including cardiovascular conditions, cancer, and diabetes, is one of the major factors positively impacting the blood preparation market dynamics. As per industry research, an estimated 129 million people in the U.S. have at least one major chronic disease. These diseases are known to result in complications such as anemia, clotting disorders, and immune system deficiencies, which require frequent blood transfusions, platelet replacement therapy, and plasma treatments. For instance, according to the National Blood Collection and Utilization Survey (NBCUS) report, in 2021, 10,764,000 units of whole blood-derived and apheresis red blood cells (RBCs) were transfused in the United States. Moreover, the growing geriatric population across the globe, exacerbating the need for blood transfusion as these individuals are more prone to chronic illnesses and associated complications, is bolstering the expansion of this industry.

Introduction of Government Initiatives and Healthcare Infrastructure Development

The introduction of various government initiatives to improve healthcare infrastructure and ensure a stable blood supply is enhancing the blood preparation market size. The increasing government focus on investing in initiatives that promote blood donation, improve blood bank facilities, and enhance the overall safety and availability of blood products is boosting the market growth. For instance, the Government of India (GOI), through blood transfusion services, has been supporting 1131 blood banks in the public and charitable sector with respect to manpower, procurement of blood bags and testing kits, conduction of voluntary blood donation (VBD) camps, and information education communication (IEC) activities. In addition, governments are implementing stringent measures to ensure the quality and safety of blood products, which helps build trust among healthcare providers and patients. For example, e-RaktKosh, an initiative of the Government of India to monitor the blood banks, is an integrated blood bank management information system that interconnects all the blood banks into a single network.

Growing Awareness and Increasing Blood Donations

The growing awareness about the importance of blood donation and the increasing number of blood donors across the globe are boosting the blood preparation market share. Each year, an estimated 6.8 million people in the U.S. donate blood, and 13.6 million units of whole blood and red blood cells are collected. Moreover, the introduction of public health campaigns and initiatives led by governments, non-governmental organizations (NGOs), and healthcare providers to educate the public about the life-saving importance of donating blood is bolstering the market growth. Along with this, the growing demand for blood products in developed and developing countries that is leading to more structured and organized blood donation systems, which ensure a steady and reliable supply of blood, is fueling the market growth.

Blood Preparation Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on product, antithrombotic and anticoagulants type, and antithrombotic and anticoagulants application.

Breakup by Product:

  • Whole Blood
  • Red Cells
  • Granulocytes
  • Plasma
  • Platelets
  • Blood Components
  • Whole Blood Components
  • Packed Red Cells
  • Leukocyte Reduced Red Blood Cells
  • Frozen Plasma
  • Platelet Concentrate
  • Cryoprecipitate
  • Blood Derivatives

Whole blood accounts for the majority of the market share

As per the blood preparation market analysis, whole blood dominated the market due to its widespread use in various medical treatments, including surgeries, trauma care, and transfusions for patients with severe anemia or blood loss. Moreover, it contains all essential components, such as red cells, white cells, platelets, and plasma, making it versatile for multiple clinical applications. Besides this, the growing demand for whole blood in emergency and critical care settings, coupled with its crucial role in life-saving procedures, is contributing to the market growth.

Breakup by Antithrombotic and Anticoagulants Type:

  • Platelet Aggregation Inhibitors
  • Glycoprotein Inhibitors
  • COX Inhibitors
  • ADP Antagonists
  • Others
  • Fibrinolytics
  • Tissue Plasminogen Activator (TPA)
  • Streptokinase
  • Urokinase
  • Anticoagulants
  • Heparins
  • Vitamin K Antagonists
  • Direct Thrombin Inhibitors
  • Direct Factor Xa Inhibitors

Anticoagulants holds the largest share of the industry

Based on the blood preparation market overview, anticoagulants accounted for the largest market, driven by their critical role in preventing and treating blood clots, which are common in conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation. Moreover, anticoagulants are essential for managing clot-related disorders and reducing the risk of strokes and heart attacks. Besides this, their frequent use in surgical procedures and long-term treatments for patients with cardiovascular conditions is enhancing the market growth. Along with this, the increasing geriatric population, which is more prone to clotting disorders, and the development of newer anticoagulant therapies that offer improved safety and efficacy profiles are boosting the blood preparation market growth rate.

Breakup by Antithrombotic and Anticoagulants Application:

  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others

Thrombocytosis represents the leading market segment

According to the blood preparation market forecast, thrombocytosis represented the largest share in the market, due to the increasing prevalence of conditions that cause elevated platelet counts, such as myeloproliferative disorders. Moreover, thrombocytosis often leads to excessive blood clot formation, which can result in severe complications like strokes or heart attacks. Anticoagulants and antithrombotic therapies are critical for managing this condition by preventing abnormal clotting. Along with this, the growing awareness of thrombocytosis, rapid advancements in diagnostic tools, and the availability of targeted anticoagulant treatments are driving the market growth.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest blood preparation market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for blood preparation.

As per the blood preparation market report, North America is leading the market, driven by its well-established healthcare infrastructure, high prevalence of chronic diseases, and significant healthcare spending. Moreover, the growing demand for blood products, fueled by the growing incidence of conditions such as cancer, cardiovascular diseases, and anemia, which require regular blood transfusions and platelet therapies, is bolstering the market growth. Besides this, the introduction of advanced medical technologies, a strong emphasis on blood safety, and a large network of blood donation centers in the region are acting as major blood preparation market drivers.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the blood preparation industry include Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.), Sanofi S.A., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The leading players in the market are focusing on strategic collaborations, product innovations, and expanding their geographical presence to strengthen their market positions. They are investing in research and development (R&D) to introduce advanced blood products and technologies aimed at improving safety and efficacy. Moreover, several firms are enhancing their production capabilities to meet the rising demand for plasma-derived therapies and other blood components. Besides this, they are forming partnerships with hospitals, blood banks, and healthcare institutions to secure stable supply chains and improve accessibility.

Key Questions Answered in This Report

  • 1.What was the size of the global blood preparation market in 2025?
  • 2.What is the expected growth rate of the global blood preparation market during 2026-2034?
  • 3.What are the key factors driving the global blood preparation market?
  • 4.What has been the impact of COVID-19 on the global blood preparation market?
  • 5.What is the breakup of the global blood preparation market based on the product?
  • 6.What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants type?
  • 7.What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants application?
  • 8.What are the key regions in the global blood preparation market?
  • 9.Who are the key players/companies in the global blood preparation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Preparation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Whole Blood
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Red Cells
      • 6.1.2.2 Granulocytes
      • 6.1.2.3 Plasma
      • 6.1.2.4 Platelets
    • 6.1.3 Market Forecast
  • 6.2 Blood Components
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Whole Blood Components
      • 6.2.2.2 Packed Red Cells
      • 6.2.2.3 Leukocyte Reduced Red Blood Cells
      • 6.2.2.4 Frozen Plasma
      • 6.2.2.5 Platelet Concentrate
      • 6.2.2.6 Cryoprecipitate
    • 6.2.3 Market Forecast
  • 6.3 Blood Derivatives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Antithrombotic and Anticoagulants Type

  • 7.1 Platelet Aggregation Inhibitors
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Glycoprotein Inhibitors
      • 7.1.2.2 COX Inhibitors
      • 7.1.2.3 ADP Antagonists
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Fibrinolytics
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Tissue Plasminogen Activator (TPA)
      • 7.2.2.2 Streptokinase
      • 7.2.2.3 Urokinase
    • 7.2.3 Market Forecast
  • 7.3 Anticoagulants
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Heparins
      • 7.3.2.2 Vitamin K Antagonists
      • 7.3.2.3 Direct Thrombin Inhibitors
      • 7.3.2.4 Direct Factor Xa Inhibitors
    • 7.3.3 Market Forecast

8 Market Breakup by Antithrombotic and Anticoagulants Application

  • 8.1 Thrombocytosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pulmonary Embolism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Renal Impairment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Angina Blood Vessel Complications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Boehringer Ingelheim International GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bristol-Myers Squibb Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Daiichi Sankyo Company Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 GlaxoSmithKline PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson Services Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 LEO Pharma A/S
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Preparation Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Preparation Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Blood Preparation Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Blood Preparation Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Type (in %), 2025
  • Figure 6: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Application (in %), 2025
  • Figure 7: Global: Blood Preparation Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Blood Preparation (Whole Blood) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Blood Preparation (Whole Blood) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Blood Preparation (Blood Components) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Blood Preparation (Blood Components) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Blood Preparation (Blood Derivatives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Blood Preparation (Blood Derivatives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Blood Preparation (Fibrinolytics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Blood Preparation (Fibrinolytics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Blood Preparation (Anticoagulants) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Blood Preparation (Anticoagulants) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Blood Preparation (Thrombocytosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Blood Preparation (Thrombocytosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Blood Preparation (Pulmonary Embolism) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Blood Preparation (Pulmonary Embolism) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Blood Preparation (Renal Impairment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Blood Preparation (Renal Impairment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Blood Preparation (Angina Blood Vessel Complications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Blood Preparation (Angina Blood Vessel Complications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Blood Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Blood Preparation Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Blood Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Blood Preparation Industry: SWOT Analysis
  • Figure 80: Global: Blood Preparation Industry: Value Chain Analysis
  • Figure 81: Global: Blood Preparation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Preparation Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Blood Preparation Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Type (in Million USD), 2026-2034
  • Table 4: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Application (in Million USD), 2026-2034
  • Table 5: Global: Blood Preparation Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Blood Preparation Market: Competitive Structure
  • Table 7: Global: Blood Preparation Market: Key Players